Literature DB >> 22870472

Stem cell therapy: resetting autoimmunity or postponing the inevitable?

Jacob M van Laar.   

Abstract

Entities:  

Year:  2011        PMID： 22870472      PMCID： PMC3389388          DOI： 10.1177/1759720X11402117

Source DB:  PubMed          Journal:  Ther Adv Musculoskelet Dis        ISSN： 1759-720X            Impact factor:   5.346


× No keyword cloud information.
  20 in total

1.  High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis.

Authors:  Sarah Bingham; Douglas Veale; Ursula Fearon; John D Isaacs; Gareth Morgan; Paul Emery; Dennis McGonagle; Richard Reece; Roy Clague; John A Snowden
Journal:  Arthritis Rheum       Date:  2002-03

2.  Decrease in synovial cellularity and cytokine expression after autologous stem cell transplantation in patients with juvenile idiopathic arthritis.

Authors:  Danielle M C Brinkman; Rebecca ten Cate; Jaak M Vossen; Tom J M Smeets; Maarten C Kraan; Paul P Tak
Journal:  Arthritis Rheum       Date:  2002-04

3.  CD34+ cells home, proliferate, and participate in capillary formation, and in combination with CD34- cells enhance tube formation in a 3-dimensional matrix.

Authors:  Maarten B Rookmaaker; Marianne C Verhaar; Cindy J M Loomans; Robert Verloop; Erna Peters; Peter E Westerweel; Toyoaki Murohara; Frank J T Staal; Anton Jan van Zonneveld; Pieter Koolwijk; Ton J Rabelink; Victor W M van Hinsbergh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-07-14       Impact factor: 8.311

4.  Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease.

Authors:  M Aschwanden; T Daikeler; K A Jaeger; C Thalhammer; A Gratwohl; M Matucci-Cerinic; A Tyndall
Journal:  Ann Rheum Dis       Date:  2008-07       Impact factor: 19.103

5.  Transplantation of autoimmune potential. IV. Reversal of the NZB autoimmune syndrome by bone marrow transplantation.

Authors:  J I Morton; B V Siegel
Journal:  Transplantation       Date:  1979-02       Impact factor: 4.939

6.  Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system.

Authors:  Tobias Alexander; Andreas Thiel; Oliver Rosen; Gero Massenkeil; Arne Sattler; Siegfried Kohler; Henrik Mei; Hartmut Radtke; Erika Gromnica-Ihle; Gerd-Rüdiger Burmester; Renate Arnold; Andreas Radbruch; Falk Hiepe
Journal:  Blood       Date:  2008-09-29       Impact factor: 22.113

7.  Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.

Authors:  D M C Brinkman; I M de Kleer; R ten Cate; M A J van Rossum; W P Bekkering; A Fasth; M J D van Tol; W Kuis; N M Wulffraat; J M Vossen
Journal:  Arthritis Rheum       Date:  2007-07

8.  CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation.

Authors:  Zoulfia Allakhverdi; Michael R Comeau; Dirk E Smith; Dean Toy; Leandra Mfuna Endam; Martin Desrosiers; Yong-Jun Liu; Karen J Howie; Judah A Denburg; Gail M Gauvreau; Guy Delespesse
Journal:  J Allergy Clin Immunol       Date:  2008-12-06       Impact factor: 10.793

9.  Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Sarah T A Roord; Wilco de Jager; Louis Boon; Nico Wulffraat; Anton Martens; Berent Prakken; Femke van Wijk
Journal:  Blood       Date:  2008-02-06       Impact factor: 22.113

10.  Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?

Authors:  Jo N Fleming; Richard A Nash; D O McLeod; David F Fiorentino; Howard M Shulman; M Kari Connolly; Jerry A Molitor; Gretchen Henstorf; Robert Lafyatis; David K Pritchard; Lawrence D Adams; Daniel E Furst; Stephen M Schwartz
Journal:  PLoS One       Date:  2008-01-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.